![]() | Up a level |
Zhang, Anwen, Nikoloski, Zlatko, Albala, Sarah Averi, Yip, Winnie, Xu, Jin and Mossialos, Elias ORCID: 0000-0001-8664-9297
(2020)
Patient choice of health care providers in China: primary care facilities versus hospitals.
Health Systems and Reform, 6 (1).
ISSN 2328-8604
Yang, Wei, Wu, Bei, Tan, Si Ying, Li, Bingqin, Lou, Vivian W.Q., Chen, Zhuo, Chen, Xi, Fletcher, James Rupert, Carrino, Ludovico, Hu, Bo, Zhang, Anwen, Hu, Min and Wang, Yixiao (2020) Understanding health and social challenges for aging and long-term care in China. Research on Aging. ISSN 0164-0275
Lu, Weijia, Zhang, Anwen and Mossialos, Elias ORCID: 0000-0001-8664-9297
(2020)
Parental migration and self-reported health status of adolescents in China: a cross-sectional study.
EClinicalMedicine, 22.
ISSN 2589-5370
Fruehwirth, Jane Cooley, Iyer, Sriya and Zhang, Anwen (2019) Religion and depression in adolescence. Journal of Political Economy, 127 (3). 1178 - 1209. ISSN 0022-3808
Nikoloski, Zlatko, Zhang, Anwen, Hopkin, Gareth and Mossialos, Elias ORCID: 0000-0001-8664-9297
(2019)
Self-reported symptoms of depression among Chinese rural-to-urban migrants and left-behind family members.
JAMA network open, 2 (5).
e193355.
ISSN 2574-3805
Su, Meng, Zhang, Qiuli, Bai, Xueke, Wu, Chaoqun, Li, Yetong, Mossialos, Elias ORCID: 0000-0001-8664-9297, Mensah, George A, Masoudi, Frederick A, Lu, Jiapeng, Li, Xi, Salas-Vega, Sebastian, Zhang, Anwen, Lu, Yuan, Nasir, Khurram, Krumholz, Harlan M and Jiang, Lixin
(2017)
Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.
The Lancet, 390 (10112).
2559 - 2568.
ISSN 0140-6736
Zhang, Anwen, Nikoloski, Zlatko and Mossialos, Elias ORCID: 0000-0001-8664-9297
(2017)
Does health insurance reduce out-of-pocket expenditure? Heterogeneity among China's middle-aged and elderly.
Social Science & Medicine, 190.
pp. 11-19.
ISSN 0277-9536
Kanavos, Panos ORCID: 0000-0001-9518-3089, Mills, Mackenzie and Zhang, Anwen
(2019)
Pharmaceutical policy in China.
.
LSE Consulting, London, UK.